Share Email Print
cover

Proceedings Paper

Endometrial ablation using SideFire laser fiber
Author(s): Royice B. Everett
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The first successful report using the neodymium:yttrium-aluminum-garnet (Nd:YAG) Laser to control hypermenorrhea was reported in 1981. Variations on the treatment technique have been attempted to improve the amenorrhea rate. Reports using the Nd:YAG laser with the blanching or non-touch technique seem to result in a better outcome and higher rate of total amenorrhea than using the dragging technique. Due to the report of improved rates of amenorrhea when using the blanching technique and the Nd:YAG laser, a fiber was developed to direct the laser energy at right angles to the axis of the fiber, therefore allowing a total treatment of the entire uterus in a perpendicular fashion. The theoretic benefit of this would be a more complete and predictable destruction of the endometrial lining, avoiding fluid overload by coagulating and sealing of the vessels and lymphatic. After a follow-up of 12 to 36 months, 56 of the 60 patients (93%) who underwent complete endometrial ablation with the SideFireTM technique had excellent results. Total absolute amenorrhea resulted in 50 patients (83%). Contrary to earlier reports, using the rollerball electrode, this procedure technique resulted in no decrease in results in younger patients. In conclusion, this seems to be a reasonable alternative which offers improved results when compared to previously available methods using electrosurgery or the Nd:YAG laser without the use of the SideFireTM device.

Paper Details

Date Published: 17 May 1996
PDF: 6 pages
Proc. SPIE 2671, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VI, (17 May 1996); doi: 10.1117/12.239999
Show Author Affiliations
Royice B. Everett, Baptist Laser Institute and Univ. of Oklahoma Health Sciences Ctr. (United States)


Published in SPIE Proceedings Vol. 2671:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VI
C. Thomas Vangsness; Kenneth Eugene Bartels; Lloyd P. Tate; Lawrence S. Bass; Rodney A. White; Graham M. Watson; Reza S. Malek; Aaron P. Perlmutter; R. Rox Anderson; R. Rox Anderson; Royice B. Everett; Douglas E. Ott, Editor(s)

© SPIE. Terms of Use
Back to Top